Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L J Spaccavento

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
The American Journal of Cardiology|July 7, 1999
Determinants of infarct size after thrombolytic treatment in acute myocardial infarctionC J Bruce, T F Christian, G L Schaer, et al.
The American Journal of Cardiology|February 15, 1993
Myocardial infarct artery patency and reocclusion rates after treatment with duteplase at the dose used in the International Study of Infarct Survival-3. Burroughs Wellcome Study GroupJ M Kalbfleisch, P B Kurnik, U Thadani, et al.
Circulation|August 1, 1996
Beneficial effects of RheothRx injection in patients receiving thrombolytic therapy for acute myocardial infarction. Results of a randomized, double-blind, placebo-controlled trialG L Schaer, L J Spaccavento, K F Browne, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
The American Journal of Cardiology|July 7, 1999
Determinants of infarct size after thrombolytic treatment in acute myocardial infarctionC J Bruce, T F Christian, G L Schaer, et al.
The American Journal of Cardiology|February 15, 1993
Myocardial infarct artery patency and reocclusion rates after treatment with duteplase at the dose used in the International Study of Infarct Survival-3. Burroughs Wellcome Study GroupJ M Kalbfleisch, P B Kurnik, U Thadani, et al.
Circulation|August 1, 1996
Beneficial effects of RheothRx injection in patients receiving thrombolytic therapy for acute myocardial infarction. Results of a randomized, double-blind, placebo-controlled trialG L Schaer, L J Spaccavento, K F Browne, et al.
Pageof 2